Tradestie Institutional Equity Comparison Engine
MTNB vs VTVT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MTNB Overall Edge
MTNB Captures Institutional Edge (2โ0 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Matinas BioPharma Holdings, Inc. (MTNB) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VTVT at N/M Forward P/E and -29.8% operating margin (+0.0% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTVT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MTNB N/M vs VTVT N/M Fwd P/E
Growth & Margin Winner
MTNB
Op Margin 0.0% vs -29.8% ยท YoY -100.0% vs +0.0%
Momentum & Technical Winner
MTNB
1Y -31.4% vs -45.7% ยท 52W Pos 22% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
VTVT
NASDAQ
vTv Therapeutics Inc. Class A Common Stock
Pharmaceutical Preparations
$16.36
+0.8% 1D
Market Cap
$65.5M
1M Return
-41.09%
1Y Return
-45.67%
Forward P/E
N/M
Unified AI Score
38.9 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MTNB -31.35%
VTVT -45.67%
Spread: +14.32 pp (MTNB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MTNB TTM Op. Margin: 0.0%
VTVT TTM Op. Margin: -29.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTNB vs VTVT. Trailing 12-month operating profitability (MTNB 0.0% vs VTVT -29.8%) and valuation multiples (MTNB N/M vs VTVT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTNB | VTVT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $979,904 | $65.5M | Larger Scale | VTVT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | +0.0% | Higher Growth | VTVT |
| Operating Margin (TTM) Profitability | 0.0% | -29.8% | Higher Margin | MTNB |
| Net Profit Margin Profitability | 0.0% | -20.8% | Higher Margin | MTNB |
| Return on Equity (ROE) Capital Efficiency | -147.5% | -10.9% | Higher ROE | VTVT |
| 52-Week Range Position Momentum | 22% ($0โ$3) | 2% ($16โ$44) | Stronger Trend | MTNB |
| Beta / 30D Volatility Risk Regime | -7.20ฮฒ ยท 147% Vol | 1.51ฮฒ ยท 55% Vol | Lower Realized Risk | VTVT |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 38.9 / 100 (SELL) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MTNB vs VTVT Buy Guide
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
VTVT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MTNB nor VTVT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.